210 EPINEPHRINE REGULATES INTERLEUKIN-10 PRODUCTION BY A CYCLIC AMP-DEPENDENT, PROTEIN KINASE A-INDEPENDENT PATHWAY

Pathways of anti-inflammatory signaling are potential targets in developing therapeutic options for diseases of inflammation, such as sepsis. Interleukin-10 (IL-10) is an important anti-inflammatory cytokine that can be regulated by epinephrine. It has been shown that epinephrine acts through a mech...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of investigative medicine 2005-01, Vol.53 (1), p.S115
Hauptverfasser: Garbern, J. C., O'Keefe, G. E.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 1
container_start_page S115
container_title Journal of investigative medicine
container_volume 53
creator Garbern, J. C.
O'Keefe, G. E.
description Pathways of anti-inflammatory signaling are potential targets in developing therapeutic options for diseases of inflammation, such as sepsis. Interleukin-10 (IL-10) is an important anti-inflammatory cytokine that can be regulated by epinephrine. It has been shown that epinephrine acts through a mechanism involving cyclic AMP (cAMP), an important intracellular signaling molecule that is critical in regulating the immune response. cAMP has commonly been thought to act only through protein kinase A (PKA), however recent studies suggest that cAMP may also act through PKA-independent pathways. In this study we investigate the mechanism by which epinephrine regulates IL-10 cytokine production. Human promonocytic THP-1 cells were pretreated for 48 h with 100 nM vitamin D prior to stimulation with lipopolysaccharide (LPS, 100 ng/mL) and epinephrine (10 μM) for 24 h. Some cells were pretreated for 15 min with propranolol (10 μM, a β2 adrenergic receptor (β2AR) blocker), H89 (1000 nM, an inhibitor of the catalytic subunit of PKA), Rp-cAMP (300 nM, a competitive inhibitor of PKA), or SQ22536 (1000 μM, an inhibitor of adenylate cyclase) prior to stimulation with LPS and epinephrine. IL-10 cytokine production and mRNA expression levels were measured by enzyme-linked immunosorbent assay (ELISA) and reverse transcriptase-polymerase chain reaction (RT-PCR), respectively. Epinephrine significantly increased LPS-induced IL-10 cytokine production at 24 h (LPS = 24.0 ± 2.1 pg/mL vs. epinephrine + LPS = 93.7 ± 5.8 pg/mL, n=3, p≤0.001) by increasing IL-10 transcription. β2AR blockade with propranolol completely inhibited epinephrine-induced IL-10 production (propranolol + LPS = 27.6 ± 0.8 pg/mL vs. epinephrine + propranolol + LPS = 26.1 ± 1.0 pg/mL, n=3). PKA inhibition with H89 and Rp-cAMP did not reduce epinephrine-induced IL-10 production. In contrast, inhibition of adenylate cyclase with SQ22536 significantly decreased epinephrine-induced IL-10 production by 52% (p≤0.01). These results suggest that epinephrine increases IL-10 cytokine production by a cAMP-dependent, PKA-independent mechanism.
doi_str_mv 10.2310/6650.2005.00005.209
format Article
fullrecord <record><control><sourceid>proquest_bmj_p</sourceid><recordid>TN_cdi_proquest_journals_1786934182</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4045620041</sourcerecordid><originalsourceid>FETCH-LOGICAL-b672-e2765b009d5f150a89fc20cf555f2456b2da1a98d474637ba0ed7bc4594ace7b3</originalsourceid><addsrcrecordid>eNo9kE1Lw0AQhoMoWKu_wMuCV7fObrJfxzVd28WYhnSL9LQkaQIWa2tiD_57EyteZl6YZ2bgCYJbAhMaEnjgnPUJgE0AhkpBnQUjIkBiSbk47zNIghmT6jK46rotAOVM0VHQUQLIZDY12TzvK8rNbJVoZ5bIps7kiVk92xT3UJYvpqvY2UWKHtdIo3gdJzZG-iXDU5OZdGpSdz9QztgU9Ut6aZDGNv2foky7-ateXwcXTfHe1Td_fRy4J-PiOU4WMxvrBJdcUFxTwVkJoDasIQwKqZqKQtUwxhoaMV7STUEKJTeRiHgoygLqjSiriKmoqGpRhuPg7nT20O4_j3X35bf7Y_vRf_RESK7CiEjaU5MTVe62_tC-7Yr22xPwg1c_ePWDV__rtY8q_AFPWl9u</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1786934182</pqid></control><display><type>article</type><title>210 EPINEPHRINE REGULATES INTERLEUKIN-10 PRODUCTION BY A CYCLIC AMP-DEPENDENT, PROTEIN KINASE A-INDEPENDENT PATHWAY</title><source>SAGE Complete A-Z List</source><creator>Garbern, J. C. ; O'Keefe, G. E.</creator><creatorcontrib>Garbern, J. C. ; O'Keefe, G. E.</creatorcontrib><description>Pathways of anti-inflammatory signaling are potential targets in developing therapeutic options for diseases of inflammation, such as sepsis. Interleukin-10 (IL-10) is an important anti-inflammatory cytokine that can be regulated by epinephrine. It has been shown that epinephrine acts through a mechanism involving cyclic AMP (cAMP), an important intracellular signaling molecule that is critical in regulating the immune response. cAMP has commonly been thought to act only through protein kinase A (PKA), however recent studies suggest that cAMP may also act through PKA-independent pathways. In this study we investigate the mechanism by which epinephrine regulates IL-10 cytokine production. Human promonocytic THP-1 cells were pretreated for 48 h with 100 nM vitamin D prior to stimulation with lipopolysaccharide (LPS, 100 ng/mL) and epinephrine (10 μM) for 24 h. Some cells were pretreated for 15 min with propranolol (10 μM, a β2 adrenergic receptor (β2AR) blocker), H89 (1000 nM, an inhibitor of the catalytic subunit of PKA), Rp-cAMP (300 nM, a competitive inhibitor of PKA), or SQ22536 (1000 μM, an inhibitor of adenylate cyclase) prior to stimulation with LPS and epinephrine. IL-10 cytokine production and mRNA expression levels were measured by enzyme-linked immunosorbent assay (ELISA) and reverse transcriptase-polymerase chain reaction (RT-PCR), respectively. Epinephrine significantly increased LPS-induced IL-10 cytokine production at 24 h (LPS = 24.0 ± 2.1 pg/mL vs. epinephrine + LPS = 93.7 ± 5.8 pg/mL, n=3, p≤0.001) by increasing IL-10 transcription. β2AR blockade with propranolol completely inhibited epinephrine-induced IL-10 production (propranolol + LPS = 27.6 ± 0.8 pg/mL vs. epinephrine + propranolol + LPS = 26.1 ± 1.0 pg/mL, n=3). PKA inhibition with H89 and Rp-cAMP did not reduce epinephrine-induced IL-10 production. In contrast, inhibition of adenylate cyclase with SQ22536 significantly decreased epinephrine-induced IL-10 production by 52% (p≤0.01). These results suggest that epinephrine increases IL-10 cytokine production by a cAMP-dependent, PKA-independent mechanism.</description><identifier>ISSN: 1081-5589</identifier><identifier>EISSN: 1708-8267</identifier><identifier>DOI: 10.2310/6650.2005.00005.209</identifier><language>eng</language><publisher>London: Sage Publications Ltd</publisher><ispartof>Journal of investigative medicine, 2005-01, Vol.53 (1), p.S115</ispartof><rights>2015 American Federation for Medical Research, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><rights>Copyright: 2015 (c) 2015 American Federation for Medical Research, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27907,27908</link.rule.ids></links><search><creatorcontrib>Garbern, J. C.</creatorcontrib><creatorcontrib>O'Keefe, G. E.</creatorcontrib><title>210 EPINEPHRINE REGULATES INTERLEUKIN-10 PRODUCTION BY A CYCLIC AMP-DEPENDENT, PROTEIN KINASE A-INDEPENDENT PATHWAY</title><title>Journal of investigative medicine</title><description>Pathways of anti-inflammatory signaling are potential targets in developing therapeutic options for diseases of inflammation, such as sepsis. Interleukin-10 (IL-10) is an important anti-inflammatory cytokine that can be regulated by epinephrine. It has been shown that epinephrine acts through a mechanism involving cyclic AMP (cAMP), an important intracellular signaling molecule that is critical in regulating the immune response. cAMP has commonly been thought to act only through protein kinase A (PKA), however recent studies suggest that cAMP may also act through PKA-independent pathways. In this study we investigate the mechanism by which epinephrine regulates IL-10 cytokine production. Human promonocytic THP-1 cells were pretreated for 48 h with 100 nM vitamin D prior to stimulation with lipopolysaccharide (LPS, 100 ng/mL) and epinephrine (10 μM) for 24 h. Some cells were pretreated for 15 min with propranolol (10 μM, a β2 adrenergic receptor (β2AR) blocker), H89 (1000 nM, an inhibitor of the catalytic subunit of PKA), Rp-cAMP (300 nM, a competitive inhibitor of PKA), or SQ22536 (1000 μM, an inhibitor of adenylate cyclase) prior to stimulation with LPS and epinephrine. IL-10 cytokine production and mRNA expression levels were measured by enzyme-linked immunosorbent assay (ELISA) and reverse transcriptase-polymerase chain reaction (RT-PCR), respectively. Epinephrine significantly increased LPS-induced IL-10 cytokine production at 24 h (LPS = 24.0 ± 2.1 pg/mL vs. epinephrine + LPS = 93.7 ± 5.8 pg/mL, n=3, p≤0.001) by increasing IL-10 transcription. β2AR blockade with propranolol completely inhibited epinephrine-induced IL-10 production (propranolol + LPS = 27.6 ± 0.8 pg/mL vs. epinephrine + propranolol + LPS = 26.1 ± 1.0 pg/mL, n=3). PKA inhibition with H89 and Rp-cAMP did not reduce epinephrine-induced IL-10 production. In contrast, inhibition of adenylate cyclase with SQ22536 significantly decreased epinephrine-induced IL-10 production by 52% (p≤0.01). These results suggest that epinephrine increases IL-10 cytokine production by a cAMP-dependent, PKA-independent mechanism.</description><issn>1081-5589</issn><issn>1708-8267</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNo9kE1Lw0AQhoMoWKu_wMuCV7fObrJfxzVd28WYhnSL9LQkaQIWa2tiD_57EyteZl6YZ2bgCYJbAhMaEnjgnPUJgE0AhkpBnQUjIkBiSbk47zNIghmT6jK46rotAOVM0VHQUQLIZDY12TzvK8rNbJVoZ5bIps7kiVk92xT3UJYvpqvY2UWKHtdIo3gdJzZG-iXDU5OZdGpSdz9QztgU9Ut6aZDGNv2foky7-ateXwcXTfHe1Td_fRy4J-PiOU4WMxvrBJdcUFxTwVkJoDasIQwKqZqKQtUwxhoaMV7STUEKJTeRiHgoygLqjSiriKmoqGpRhuPg7nT20O4_j3X35bf7Y_vRf_RESK7CiEjaU5MTVe62_tC-7Yr22xPwg1c_ePWDV__rtY8q_AFPWl9u</recordid><startdate>200501</startdate><enddate>200501</enddate><creator>Garbern, J. C.</creator><creator>O'Keefe, G. E.</creator><general>Sage Publications Ltd</general><scope>0-V</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AM</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BGRYB</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K7.</scope><scope>K9.</scope><scope>M0O</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope></search><sort><creationdate>200501</creationdate><title>210 EPINEPHRINE REGULATES INTERLEUKIN-10 PRODUCTION BY A CYCLIC AMP-DEPENDENT, PROTEIN KINASE A-INDEPENDENT PATHWAY</title><author>Garbern, J. C. ; O'Keefe, G. E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b672-e2765b009d5f150a89fc20cf555f2456b2da1a98d474637ba0ed7bc4594ace7b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Garbern, J. C.</creatorcontrib><creatorcontrib>O'Keefe, G. E.</creatorcontrib><collection>ProQuest Social Sciences Premium Collection</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Criminal Justice Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Social Science Premium Collection</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Criminology Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Criminal Justice (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Criminal Justice Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>Journal of investigative medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Garbern, J. C.</au><au>O'Keefe, G. E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>210 EPINEPHRINE REGULATES INTERLEUKIN-10 PRODUCTION BY A CYCLIC AMP-DEPENDENT, PROTEIN KINASE A-INDEPENDENT PATHWAY</atitle><jtitle>Journal of investigative medicine</jtitle><date>2005-01</date><risdate>2005</risdate><volume>53</volume><issue>1</issue><spage>S115</spage><pages>S115-</pages><issn>1081-5589</issn><eissn>1708-8267</eissn><abstract>Pathways of anti-inflammatory signaling are potential targets in developing therapeutic options for diseases of inflammation, such as sepsis. Interleukin-10 (IL-10) is an important anti-inflammatory cytokine that can be regulated by epinephrine. It has been shown that epinephrine acts through a mechanism involving cyclic AMP (cAMP), an important intracellular signaling molecule that is critical in regulating the immune response. cAMP has commonly been thought to act only through protein kinase A (PKA), however recent studies suggest that cAMP may also act through PKA-independent pathways. In this study we investigate the mechanism by which epinephrine regulates IL-10 cytokine production. Human promonocytic THP-1 cells were pretreated for 48 h with 100 nM vitamin D prior to stimulation with lipopolysaccharide (LPS, 100 ng/mL) and epinephrine (10 μM) for 24 h. Some cells were pretreated for 15 min with propranolol (10 μM, a β2 adrenergic receptor (β2AR) blocker), H89 (1000 nM, an inhibitor of the catalytic subunit of PKA), Rp-cAMP (300 nM, a competitive inhibitor of PKA), or SQ22536 (1000 μM, an inhibitor of adenylate cyclase) prior to stimulation with LPS and epinephrine. IL-10 cytokine production and mRNA expression levels were measured by enzyme-linked immunosorbent assay (ELISA) and reverse transcriptase-polymerase chain reaction (RT-PCR), respectively. Epinephrine significantly increased LPS-induced IL-10 cytokine production at 24 h (LPS = 24.0 ± 2.1 pg/mL vs. epinephrine + LPS = 93.7 ± 5.8 pg/mL, n=3, p≤0.001) by increasing IL-10 transcription. β2AR blockade with propranolol completely inhibited epinephrine-induced IL-10 production (propranolol + LPS = 27.6 ± 0.8 pg/mL vs. epinephrine + propranolol + LPS = 26.1 ± 1.0 pg/mL, n=3). PKA inhibition with H89 and Rp-cAMP did not reduce epinephrine-induced IL-10 production. In contrast, inhibition of adenylate cyclase with SQ22536 significantly decreased epinephrine-induced IL-10 production by 52% (p≤0.01). These results suggest that epinephrine increases IL-10 cytokine production by a cAMP-dependent, PKA-independent mechanism.</abstract><cop>London</cop><pub>Sage Publications Ltd</pub><doi>10.2310/6650.2005.00005.209</doi></addata></record>
fulltext fulltext
identifier ISSN: 1081-5589
ispartof Journal of investigative medicine, 2005-01, Vol.53 (1), p.S115
issn 1081-5589
1708-8267
language eng
recordid cdi_proquest_journals_1786934182
source SAGE Complete A-Z List
title 210 EPINEPHRINE REGULATES INTERLEUKIN-10 PRODUCTION BY A CYCLIC AMP-DEPENDENT, PROTEIN KINASE A-INDEPENDENT PATHWAY
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T08%3A04%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_bmj_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=210%20EPINEPHRINE%20REGULATES%20INTERLEUKIN-10%20PRODUCTION%20BY%20A%20CYCLIC%20AMP-DEPENDENT,%20PROTEIN%20KINASE%20A-INDEPENDENT%20PATHWAY&rft.jtitle=Journal%20of%20investigative%20medicine&rft.au=Garbern,%20J.%20C.&rft.date=2005-01&rft.volume=53&rft.issue=1&rft.spage=S115&rft.pages=S115-&rft.issn=1081-5589&rft.eissn=1708-8267&rft_id=info:doi/10.2310/6650.2005.00005.209&rft_dat=%3Cproquest_bmj_p%3E4045620041%3C/proquest_bmj_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1786934182&rft_id=info:pmid/&rfr_iscdi=true